Macrogenics (MGNX) Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| MACROGENICS (NASDAQ: MGNX) | Delayed: 2.38 -0.09 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $36.11 | |||
| Open | $2.49 | 52 Week Low | $14.84 | |||
| Day High | $2.59 | P/E | 6.10 | |||
| Day Low | $2.37 | EPS | $0.39 | |||
| Volume | 744,076 | |||||
